2.85400 EUR
0.102
3.71%
Last update Dec 9, 9:30 PM CET
Main market
Day range
2.85400
2.85400
Previous close
2.75200
Open
2.85400
Access this stock data via API
Subscribe
Aclaris Therapeutics Inc.
2.85
0.10
3.71%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 16.0M 31.2M 29.8M 6.8M
Cost of revenue 13.2M 18.1M 12.0M 4.7M
Gross profit 2.8M 13.2M 17.8M 2.0M
Operating expense
Research & development 28.6M 98.4M 77.8M 43.8M
Selling general and admin 18.9M 31.1M 25.1M 23.6M
Other operating expenses
Operating income -44.8M -116.3M -85.2M -65.4M
Non operating interest income
Income
Expense
Other income expense -67.8M 27.5M -1.8M -25.5M
Pretax income -112.6M -88.8M -86.9M -90.9M
Tax provision 0 -367K 0 0
Net income -112.6M -88.5M -86.9M -90.9M
Basic EPS -1.7 -1.3 -1.3 -1.6
Diluted EPS -1.7 -1.3 -1.3 -1.6
Basic average shares 65.9M 73.2M 67.9M 59.0M
Diluted average shares 65.9M 73.2M 67.9M 59.0M
EBITDA 32.1M -134.4M -79.7M -40.1M
Net income from continuing op. -112.6M -88.5M -86.9M -90.9M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 36 minutes

14:23
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).